X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (351) 351
Journal Article (124) 124
Publication (9) 9
Book Review (5) 5
Conference Proceeding (5) 5
Book / eBook (3) 3
Paper (3) 3
Dissertation (2) 2
Book Chapter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (325) 325
hygiene (325) 325
medical or veterinary science (325) 325
preparations for medical, dental, or toilet purposes (325) 325
chemistry (224) 224
metallurgy (223) 223
physics (193) 193
biochemistry (156) 156
microbiology (155) 155
beer (154) 154
enzymology (154) 154
mutation or genetic engineering (154) 154
spirits (154) 154
vinegar (154) 154
wine (154) 154
general tagging of cross-sectional technologies spanning over several sections of the ipc (152) 152
general tagging of new technological developments (152) 152
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (152) 152
technologies or applications for mitigation or adaptation againstclimate change (152) 152
investigating or analysing materials by determining theirchemical or physical properties (136) 136
measuring (136) 136
testing (136) 136
specific therapeutic activity of chemical compounds ormedicinal preparations (135) 135
technologies for adaptation to climate change (128) 128
manufacture or treatment of nanostructures (112) 112
measurement or analysis of nanostructures (112) 112
nanotechnology (112) 112
performing operations (112) 112
specific uses or applications of nanostructures (112) 112
transporting (112) 112
organic chemistry (96) 96
compositions thereof (93) 93
culture media (93) 93
microorganisms or enzymes (93) 93
propagating, preserving or maintaining microorganisms (93) 93
peptides (84) 84
index medicus (70) 70
enzymes (63) 63
compositions based thereon (58) 58
derivatives thereof (58) 58
organic macromolecular compounds (58) 58
polysaccharides (58) 58
their preparation or chemical working-up (58) 58
calculating (51) 51
computing (51) 51
counting (51) 51
data processing systems or methods, specially adapted foradministrative, commercial, financial, managerial, supervisoryor forecasting purposes (51) 51
systems or methods specially adapted for administrative,commercial, financial, managerial, supervisory or forecastingpurposes, not otherwise provided for (51) 51
humans (49) 49
animals (37) 37
climate change mitigation technologies in the production orprocessing of goods (26) 26
mice (26) 26
female (21) 21
cell biology (20) 20
nucleic acids (16) 16
nucleosides (16) 16
nucleotides (16) 16
sugars (16) 16
male (13) 13
analysis (11) 11
biochemistry & molecular biology (11) 11
immunology (11) 11
mice, nude (11) 11
oncology (11) 11
research (11) 11
cancer (10) 10
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (10) 10
aged (9) 9
compositions of macromolecular compounds (9) 9
compositions or test papers therefor (9) 9
condition-responsive control in microbiological orenzymological processes (9) 9
measuring or testing processes involving enzymes, nucleicacids or microorganisms (9) 9
multidisciplinary sciences (9) 9
processes of preparing such compositions (9) 9
breast-cancer (8) 8
health aspects (8) 8
transfection (8) 8
xenograft model antitumor assays (8) 8
abridged index medicus (7) 7
antigens (7) 7
middle aged (7) 7
nanoparticles (7) 7
research paper (7) 7
adult (6) 6
anti-cea antibody (6) 6
cell adhesion (6) 6
cell line, tumor (6) 6
chemotherapy (6) 6
human colon-cancer (6) 6
human pancreatic-cancer (6) 6
in-vivo (6) 6
japan (6) 6
l-selectin (6) 6
lymphocytes (6) 6
metastasis (6) 6
molecular sequence data (6) 6
neutrophils - physiology (6) 6
nude mice (6) 6
pdox (6) 6
proteins (6) 6
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (462) 462
French (135) 135
German (49) 49
Chinese (29) 29
Spanish (20) 20
Korean (18) 18
Portuguese (13) 13
Japanese (11) 11
Russian (5) 5
Danish (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 1/2015, Volume 112, Issue 2, pp. E156 - E165
Current treatments to control pathological or unwanted immune responses often use broadly immunosuppressive drugs. New approaches to induce antigen-specific... 
Nanoparticles | Rapamycin | Anti-drug antibodies | Immune tolerance | Immunotherapy | THERAPEUTICS | anti-drug antibodies | IMMUNITY | TOLEROGENIC DENDRITIC CELLS | RISK-FACTORS | MULTIDISCIPLINARY SCIENCES | FACTOR-VIII | MECHANISMS | RESPONSES | immune tolerance | IMMUNOGENICITY | nanoparticles | UNRESPONSIVENESS | immunotherapy | rapamycin | Factor VIII - immunology | Oligodeoxyribonucleotides - administration & dosage | Nanoparticles - chemistry | Ovalbumin - immunology | Immunosuppression - methods | Nanocapsules - administration & dosage | Humans | Encephalomyelitis, Autoimmune, Experimental - immunology | Hypersensitivity, Delayed - immunology | Nanocapsules - chemistry | Peptides - administration & dosage | Antigens - administration & dosage | CD4-Positive T-Lymphocytes - immunology | Immunity, Humoral | Peptide Fragments - immunology | Proteins - administration & dosage | Female | Immunosuppressive Agents - administration & dosage | Disease Models, Animal | Lactic Acid - chemistry | Peptides - chemistry | Hemophilia A - immunology | Peptide Fragments - administration & dosage | Peptides - immunology | Immune Tolerance | Hemophilia A - therapy | Hypersensitivity, Delayed - therapy | Antigens - chemistry | Proteins - immunology | Encephalomyelitis, Autoimmune, Experimental - therapy | Sirolimus - administration & dosage | Animals | Ovalbumin - administration & dosage | Recombinant Proteins - immunology | Polyglycolic Acid - chemistry | Encephalomyelitis, Autoimmune, Experimental - prevention & control | Mice | Mice, Inbred BALB C | Nanoparticles - administration & dosage | Hemocyanins - administration & dosage | Proteins - chemistry | Antigens | Usage | Research | Health aspects | Immunological tolerance | Immunological research | Immunology | Polymers | Chemical synthesis | Immune system | Index Medicus | Biological Sciences | PNAS Plus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2008, Volume 358, Issue 23, pp. 2457 - 2467
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 6, pp. e21106 - e21106
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2010, Volume 5, Issue 2, pp. e9364 - e9364
Journal Article
Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 72 - 72
Journal Article
Vaccine, ISSN 0264-410X, 2014, Volume 32, Issue 24, pp. 2882 - 2895
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2008, Volume 359, Issue 25, pp. 2674 - 2684
Journal Article
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 4098 - 13
Journal Article
PLOS ONE, ISSN 1932-6203, 06/2018, Volume 13, Issue 6, pp. e0197694 - e0197694
We previously reported that synthetic vaccine particles (SVP) encapsulating antigens and TLR agonists resulted in augmentation of immune responses with minimal... 
IMMUNE-RESPONSE | NANOPARTICLES | CELLS | WOMEN | THERAPEUTIC VACCINE | PEPTIDE VACCINATION | MULTIDISCIPLINARY SCIENCES | HUMAN-PAPILLOMAVIRUS 16 | CANCER | ESTABLISHED TUMORS | ANTIGEN | T-Lymphocytes, Cytotoxic - immunology | Lung Neoplasms - drug therapy | Cancer Vaccines - administration & dosage | Humans | Toll-Like Receptors - immunology | Papillomavirus E7 Proteins - immunology | Lung Neoplasms - pathology | Vaccines, Synthetic - immunology | Toll-Like Receptors - agonists | Immunity, Cellular - immunology | Lung Neoplasms - immunology | Animals | Immunity, Cellular - drug effects | Lymphocyte Activation - drug effects | Immunotherapy | Cell Line, Tumor | Female | Mice | Vaccines, Synthetic - administration & dosage | Cancer vaccines | Oncology, Experimental | Research | T cells | Health aspects | Methods | Synthetic vaccines | Cancer | Encapsulation | Animal models | Peptides | CD8 antigen | Antigen processing | Effector cells | Cytotoxicity | Lymphocytes T | Vaccines | Immunosuppressive agents | Proteins | Inoculation | Human papillomavirus | Lymphocytes | Primates | Deoxyribonucleic acid--DNA | Recombinant | Formulations | Antigen presentation | Antigens | Immunization | Immunological memory | Memory cells | Immune response | Cytokines | Dendritic cells | Adjuvants | Poly (I:C) | Inflammation | Computer memory | Immune checkpoint | Lymphocytes B | Laboratory animals | Cervical cancer | Tumors | Index Medicus | Deoxyribonucleic acid | DNA | Memory (computers)
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 11/2009, Volume 102, Issue 5, pp. 900 - 906
The initial choice of anticoagulant therapy administered in emergency departments for acute coronary syndromes (ACS) has important consequences for subsequent... 
Arterial thrombosis | heparins | thrombin | coagulation inhibitors | Acute Myocardial Infarction | Theme Issue Article | Coagulation inhibitors | Thrombin | Acute myocardial infarction | Heparins | ENOXAPARIN | ANTICOAGULANTS | STRATEGY | TRIAL | HIGH-RISK PATIENTS | THROMBIN GENERATION | SUPERIOR | PERIPHERAL VASCULAR DISEASE | arterial thrombosis | HEMATOLOGY | FACTOR-XA | INTERVENTION | acute myocardial infarction | UNFRACTIONATED HEPARIN | Injections, Intravenous | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Thrombin - antagonists & inhibitors | Heparin, Low-Molecular-Weight - isolation & purification | Biological Availability | Male | Heparin, Low-Molecular-Weight - therapeutic use | Anticoagulants - toxicity | Anticoagulants - chemistry | Swine | Injections, Subcutaneous | Drug Design | Drug Evaluation, Preclinical | Anticoagulants - isolation & purification | Disease Models, Animal | Rabbits | Heparin, Low-Molecular-Weight - toxicity | Heparin, Low-Molecular-Weight - chemistry | Anticoagulants - therapeutic use | Intestinal Mucosa - chemistry | Acute Coronary Syndrome - drug therapy | Aortic Diseases - drug therapy | Animals | Aorta, Abdominal | Arterial Occlusive Diseases - drug therapy | Anticoagulants - pharmacology | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage
Journal Article